Gene
Promoter May Predispose to Severe Silicosis in Black
South African Miners
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Susceptibility to silicosis is in part genetically determined. Polymorphisms in the promoter region of tumor necrosis factor (TNF)-
,
a cytokine with a central role in the pathophysiology of silicosis,
have been associated with predisposition to several infectious and
inflammatory diseases. Polymorphisms at positions
308,
238,
and
376 in the TNF-
promoter region were compared in nine
patients with severe silicosis with International Labour Office (ILO)
grade 3 nodularity, 112 patients with less severe silicosis (ILO
grades 1/1 to 2/2), and 120 black South African gold miners without silicosis (ILO grades 0/0) in an age-frequency-matched case-
control study. There were no significant differences between miners with less severe silicosis and controls at any loci in the TNF-
promoter region, but miners with severe silicosis were significantly
more likely than controls to have
238A (33% versus 6%, Fisher's
exact p value = 0.022) and
376A (33% versus 5%, Fisher's exact
p value = 0.016). These alleles were in linkage disequilibrium (p < 0.001), and so were not independent. The association remained
significant (Fisher's exact p values = 0.011 and 0.011, respectively)
when analysis was limited to the majority tribe (Basotho), which
included all subjects with severe silicosis. Subjects with severe silicosis were also significantly more likely to have the
308A allele
(Fisher's exact p value = 0.034), but this result was confounded by
ethnicity and was not significant within Basotho tribe members
(Fisher's exact p value = 0.15). TNF-
promoter polymorphisms are
associated with severe, but not less severe, silicosis in this population. A predominant effect on disease severity, rather than on disease frequency, appears to be a general feature of promoter polymorphism in diseases in which TNF-
has a critical role.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: allele; genotyping; silicosis; tumor necrosis factor-
Silicosis is an occupational fibrotic lung disease resulting from inhalation of microscopic crystalline silica particles (1). There is a clear relationship between increased cumulative silica exposure and increased risk of silicosis (2, 3). There is also an intensity effect, in that even brief exposure to extremely high concentrations of silica can result in acute silicosis, pathologically distinct from the chronic form of disease that results from exposure to lower concentrations of silica over a period of many years (4). In addition, there appears to be quite pronounced individual variation in the severity of silicosis, suggesting that genetic factors may influence susceptibility to this disease (5).
Silicotic inflammation and fibrosis are initiated when alveolar phagocytes contact or ingest silica particles and become
activated, but are unable to further degrade the particles (8).
Cytokines and other fibrogenic mediators are released into
the local tissues and stimulate an inflammatory response, followed by fibroblast proliferation and collagenization (8). There
is a particularly strong body of evidence from experimental
animal studies to suggest that tumor necrosis factor (TNF)-
plays an important causal role in the inflammatory and fibrotic response to acute challenge with silica (9).
Single nucleotide polymorphisms (SNPs) in the TNF promoter region have been associated with susceptibility to a number of fibrotic, inflammatory, and infectious diseases other than
silicosis (13), including pulmonary conditions (22). A
small case-control study of 18 Belgian subjects with coal
worker's pneumoconiosis (CWP) reported an association of this
condition with the
308A TNF-
promoter allele (26). Reanalysis of the published data with correction for the small number of
subjects shows that this association was of borderline significance (p = 0.08), but the results were notable for the high prevalence (50%) of a relatively uncommon allele,
308A, among
cases of CWP, in most of which the disease was in an early stage.
This raised the possibility of a large fraction of pneumoconiosis
being attributable to TNF-
promoter polymorphism.
The main aim of the present study was to investigate the
role of SNPs in the TNF-
promoter region in determining susceptibility to silicosis in black South African gold miners. The
prevalence of chronic silicosis is high among South African
miners (27), affecting more than 20% of men aged 40 yr or
more at the mines that were the focus of this study (28, 29),
and carrying the major health consequences of greatly increased susceptibility to tuberculosis (TB) (28, 30) and increased risk of death from respiratory causes (31).
| |
METHODS |
|---|
|
|
|---|
Case and Control Selection and Specimen Collection
Case patients and control subjects were recruited from a single workforce in the Free State, South Africa. Case patients were identified from company records of compensation claims for silicosis uncomplicated by TB during the period from 1994 to 1997, and their selection was based entirely on annual screening radiographs. Potential control subjects were randomly selected from three separate age groups (30 to 39 yr, 40 to 49 yr, and 50 yr or older) of the remaining employees. Silicosis is strongly associated with age and years worked as a miner (29). Control subjects were randomly selected from each age group on the basis of age-specific silicosis prevalence data (28), to enable an approximate frequency match with the age distribution of cases of the disease.
Miniradiographs (10 × 10 cm), taken annually for screening purposes, were graded for silicosis with the International Labour Office (ILO) system (32). Radiographs were graded independently by two readers without reference to personal details or case status, with final grades reached by consensus in cases of initial disagreement. The ILO system was designed for use with standard-sized films, but the use of miniradiographs for detecting silicosis was validated in a separate study involving the same workforce as in the present study (29). Radiographs from all potential case subjects were graded as showing silicosis of ILO grades 1/ 1 or above by both readers. Cases were graded into the three categories of early, moderate, and severe disease, corresponding to ILO grades 1/1 to 1/2, 2/ 1 to 2/3, and 3/ 2 to 3/3, respectively. Control subjects with radiographs graded by both readers as showing no evidence of silicosis (ILO grade 0/0) were asked to participate. Written consent or witnessed verbal consent was obtained from all participants. Approval for the study was obtained from the Ethics Committees of the London School of Hygiene and Tropical Medicine and the Ernest Oppenheimer Hospital, Welkom.
A sample of blood (8 ml) was collected into heparin from each consenting subject, and DNA was prepared through two rounds of phenol:chloroform:isoamyl alcohol (25:24:1) and one round of chloroform extraction, followed by ethanol precipitation and dissolution of the pellet in 100 µl of sterile water.
Polymerase Chain Reaction of TNF-
Fragments
The polymerase chain reaction (PCR) and nested PCR were performed on DNA samples, using 1 µl of DNA (or 1 µl of preamplified DNA); 50 mM KCl; 10 mM Tris-HCl; 0.1% Triton X-100; 2.5 mM MgCl2; 200 µM each of deoxyadenosine, deoxyguanosine, deoxythymidine, and deoxycytosine triphosphate; 0.5 µM of each primer; and 1 unit of Taq polymerase with a total volume of 20 µl. DNA was heated to 95° C for 3 min; and subjected to 20 cycles of PCR at 95° C for 1 min, at 60° C for 1 min, and at 72° C for 1 min, with primers described by McGuire and colleagues (13). On some samples, which had unexpectedly poor DNA quality, a nested PCR was performed under the same conditions but with the following primers: TNF-423Fwd: 5'-GC CCCTCCCAGTTCTAGTTC-3'; and TNF-225Rev: 5'-GATACCCCT CACACTCCCCA1-3'.
TNF-
Allele-Specific Oligonucleotide Probing
PCR products were denatured for 2 min at 94° C, and genotyping was
performed with sequence-specific oligonucleotide (SSO) probing. Oligonucleotide probes of 18-mer were designed for each allele at each
polymorphic site. These were as follows: TNF-
-376G: 5'-TGTCTG
GAAGTTAGAAGG-3'; TNF-
-376A: 5'-TGTCTGGAAATTAGAA
GG-3'; TNF-
-308G: 5'-AGGGGCATGGGGACGGGG-3'; TNF-
-308A: 5'-AGGGGCATGAGGACGGGG-3'; TNF-
-238G: 5'-GAA
TCGGAGCAGGGAGGA-3'; TNF-
-238A: 5'-GAATCAGAGCAG GGAGGA-3'.
Probes were 3' end-labeled with digoxigenin (Boehringer Mannheim, Mannheim, Germany) and used at 2 pmol/ml. Hybridization was performed in 5-ml volumes of 3M tetramethylammonium chloride (TMAC), 50 mM Tris, 0.1% sodium dodecyl sulfate (SDS), and 2 mM ethylene diamine tetraacetic acid (EDTA) solution at 53° C for 1.5 h, after which excess probe was removed by washing twice for 10 min each in 2× saline-sodium phosphate-EDTA/0.1% SDS at room temperature and twice for 10 min each in 3M TMAC buffer at 56° C. Detection of hybridization was done with antidigoxigenin Fab antibody (alkaline phosphatase conjugated) and chemoluminescent detection was done with cold shock protein D (CSPD) according to the manufacturer's recommendations (Boehringer Mannheim). Allele scoring was checked by two independent investigators.
Data Analysis
Data were analyzed with STATA 5.0 software (Stata Corporation, College Station, TX). The chi-squared and Fisher exact tests were used to test the significance of associations between categorical variables. The significance of differences in employment duration and age was determined with t tests.
| |
RESULTS |
|---|
|
|
|---|
Baseline characteristics of the 121 case and 120 control participants are shown in Table 1. All were black African men. Participation rates were 79% and 74% for approached case and control subjects, respectively. Participation rates were significantly lower in the Basotho (70%) than in other tribes (88%, p < 0.001), making Basothos relatively underrepresented in both the case and control populations. Case and control subjects were well matched for age, but there were significant differences in employment duration and job type, consistent with the known association between duration and intensity of dust exposure and silicosis. There was also a significant association between tribe and case status, with Basothos being overrepresented in the case populations. This remained significant when nonparticipants were included in the analysis (p = 0.015), and so reflects a genuine association of tribe with disease in the initially selected subjects, rather than an artefact introduced by the difference in refusal rates of Basothos.
|
TNF polymorphisms were not significantly associated with
age, type of job, or mean years spent as a miner, but were significantly associated with tribal group and grade of silicosis. Basotho tribe members had a higher frequency of
308A alleles
than did members of other tribes, with the combined AA/AG
frequencies being 46% for Basothos, 33% for Xhosas, and
25% for members of other tribes (Fisher's exact p = 0.033),
but there were no significant tribal variations at the
238 or
376 loci. There was strong linkage disequilibrium between
SNPs at positions
238 and
376, as previously found for
West and East Africans (14), so that the
376A allele occurred only in association with
238A (p < 0.001).
Case status was unrelated to polymorphism at any locus.
The respective frequencies of AA/AG alleles in cases and controls were 40% and 39% at
308 (Fisher's exact p = 1.0), 8.3%
and 5.8% at
238 (Fisher's exact p = 0.62), and 7.4% and
5.0% at
376 (Fisher's exact p = 0.60). However, there was a
significant association between AG/AA alleles at
238 and
376 and silicosis grade, suggesting a possible association between TNF promoter polymorphisms and silicosis severity.
This possibility was explored further, as shown in Table 2. The
main finding was of a high prevalence of rare alleles among the
subjects with severe (ILO grade 3) silicosis. At each of the
three loci there were significant differences between the subjects with severe silicosis and controls, but not between subjects with early/moderate silicosis and controls. The frequency of A alleles (AA or AG) at each locus was also significantly
higher among subjects with severe silicosis than among those
with less severe silicosis (Fisher's exact p values = 0.028, 0.027, and 0.019 for the
308,
238, and
376 loci, respectively).
|
There was no significant association between TNF alleles and
age, employment duration, or job type, so that the associations between TNF alleles and severe silicosis are unlikely to have been due to confounding by any of these variables. There was
potential confounding with tribe, however, since A alleles at
the
308 locus were significantly more common in members of
the Basotho than in those of other tribes (Figure 1), and all subjects with severe silicosis were Basotho (Fisher's exact p value = 0.012 for the association between severe silicosis and Basotho
tribe membership). Furthermore, the TNF gene lies within the
highly polymorphic human leukocyte antigen (HLA) region,
which is known to vary considerably with ethnicity (14).
|
Because of the small number of cases of severe silicosis, all
of which involved members of a single tribe, direct adjustment for potential confounding by tribe and/or HLA haplotype was
not possible. Instead, we repeated the analysis, limiting all
subjects to members of the Basotho tribe, as shown in the
lower half of Table 2. There was confounding at the
308 locus, in that A allele frequency did not vary significantly between controls and subjects with severe silicosis among Basotho tribe members (p = 0.15). However, the association
with AA/AG at the
238 and
376 sites remained significant
when the analysis was limited to Basotho tribe members only
(Fisher's exact p = 0.011). Therefore, confounding does not
explain this association: a causal relationship remains possible.
| |
DISCUSSION |
|---|
|
|
|---|
Silicosis, one of the most extensively studied fibrotic lung diseases, remains a common occupational disease in industrializing countries, despite being preventable by dust control measures (1, 27). The risk of disease is related to total dose and intensity of exposure to silica dust (1), but there is also strong evidence for individual variation in susceptibility to silicosis both in humans (5) and in experimental animals (6, 7, 12, 33). Although environmental factors may also contribute (33), pronounced variability according to strain has been demonstrated for inbred mice (6, 7), implying that susceptibility to silicosis is at least partly determined by genetic factors.
The present study demonstrates significant associations between the
238 and
376 A alleles of the TNF-
promoter
and severe silicosis among black South African mineworkers.
The
238A and
376A alleles are in linkage disequilibrium,
as in other African populations (14), so that the associations at
these loci are not independent. The association with severe silicosis and the
308A allele was more tentative, and, unlike
the association with
238A and
376A, was not significant
when single-tribe subanalysis was performed to investigate
potential confounding by tribal background. This polymorphism, however, is of particular interest in having been previously associated with CWP in Europeans (26). In the present
study, significant differences were found only when subjects with severe silicosis were compared either with unaffected
control subjects or with subjects with less severe silicosis, but
there were no differences between control subjects and those
with less severe disease. This is in contrast to CWP in Europeans, in whom a borderline significant association between the
308A allele and early to moderate pneumoconiosis was reported for 18 case and 60 control participants in Belgium (26).
Our results have to be interpreted with caution because of
the small numbers of subjects and because associations were
found only on subgroup analysis, but it is striking that TNF-
promoter polymorphisms have been associated only with the
most severe manifestations of disease in a number of other
studies (13, 14, 17, 21). For example, the
308A and
376A
alleles are associated with susceptibility to cerebral malaria,
but not to less severe episodes of the disease (13, 14), and the
308A allele has been associated with a poor prognosis rather
than an increased risk of meningococcal disease (17), septic
shock (18), and inflammatory bowel disease (21).
Polymorphisms in the TNF-
promoter region are unusually
strong candidates as putative silicosis-susceptibility loci, since TNF-
has a central causal role in the pathophysiology of acute silicosis (9), and significant associations between silicosis and certain HLAs have been reported (34, 35), but with inconsistency of the implicated antigens in different populations, suggesting linkage disequilibrium with a nearby susceptibility locus, rather than a genuine HLA effect. The TNF-
locus lies
within the HLA complex, so that linkage disequilibrium with
HLA antigens would be expected among diseases associated
with polymorphisms in the TNF-
promoter region (14). The
basis for associations between TNF-
promoter polymorphisms
and disease susceptibilities is becoming clearer. In some cases
SNPs have been associated with functional effects such as binding of nuclear transcription factors, increased basal or inducible
transcriptional activity, or increased TNF-
production in vivo
(14, 16, 24, 36). The genetics and function of this region,
however, remain incompletely determined (38).
The main finding of the present study is that individual variation in the severity of chronic silicosis, but not overall susceptibility to the disease, may be partly explained by polymorphisms in the TNF-
promoter region. If this is confirmed in other populations, then silicosis joins a number of other diseases in which TNF-
plays a central pathophysiologic role, and for which promoter region polymorphisms affect disease severity but not frequency.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. E. L. Corbett, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. E-mail: elizabeth.corbett{at}lshtm.ac.uk
(Received in original form October 9, 2000 and accepted in revised form December 6, 2001).
Acknowledgments: The authors thank Philip Herselman for reading radiographs, Themba Moyake, Victor Mchunu, and Eddison Zulu for organizing specimen collection for the study, and Richard Hayes for helpful discussions during design of the study.
Supported by The Wellcome Trust, United Kingdom.
| |
References |
|---|
|
|
|---|
1. Becklake MR. The mineral dust diseases. Tuberc Lung Dis 1992; 73: 13-20 [Medline].
2. Nagelschmidt G. The relationship between lung dust and lung pathology in pneumoconiosis. Br J Ind Med 1960; 17: 247-259 .
3. Hughes JM. Radiographic evidence of silicosis in relation to silica exposure. Appl Occup Environ Hyg 1995; 10: 1064-1069 .
4. Checkoway H, Rice CH. Time-weighted averages, peaks, and other indices of exposure in occupational epidemiology. Am J Ind Med 1992; 21: 25-33 [Medline].
5. Katsnelson BA, Polzik EV, Privalova LI. Some aspects of the problem of individual predisposition to silicosis. Environ Health Perspect 1986; 68: 175-185 [Medline].
6. Ohtsuka Y, Munakata M, Ukita H, Takahashi T, Satoh A, Homma Y, Kawakami Y. Increased susceptibility to silicosis and TNF-alpha production in C57BL/6J mice. Am J Respir Crit Care Med 1995; 152: 2144-2149 [Abstract].
7. Davis GS, Leslie KO, Hemenway DR. Silicosis in mice: effects of dose, time, and genetic strain. J Environ Pathol Toxicol Oncol 1998; 17: 81-97 [Medline].
8.
Mossman BT,
Churg A.
Mechanisms in the pathogenesis of asbestosis
and silicosis.
Am J Respir Crit Care Med
1998;
157:
1666-1680
9. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990; 344: 245-247 [Medline].
10. Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 1994; 7: 515-518 [Abstract].
11. Savici D, He B, Geist LJ, Monick MM, Hunninghake GW. Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. Exp Lung Res 1994; 20: 613-625 [Medline].
12.
Ortiz LA,
Lasky J,
Lungarella G,
Cavarra E,
Martorana P,
Banks WA,
Peschon JJ,
Schmidt HL,
Brody AR,
Friedman M.
Upregulation of the p75
but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice.
Am J Respir Cell Mol Biol
1999;
20:
825-833
13. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510 [Medline].
14. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150 [Medline].
15. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999; 179: 287-290 [Medline].
16. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahid OS, Jennings R, Mbena E, Mabey DC. Scarring trachoma is associated with polymorphism in the tumour necrosis alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 1997; 65: 1003-1006 [Abstract].
17. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-880 [Medline].
18.
Mira JP,
Cariou A,
Grall F,
Delclaux C,
Losser MR,
Heshmati F,
Cheval C,
Monchi M,
Teboul JL,
Riche F,
Leleu G,
Arbibe L,
Mignon A,
Delpech M,
Dhainault JF.
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a
multicenter study.
JAMA
1999;
282:
561-568
19.
Brinkman BM,
Huizinga TW,
Kurban SS,
van der Velde EA,
Schreuder GM,
Hazes JM,
Breedveld FC,
Verweij CL.
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?
Br J Rheumatol
1997;
36:
516-521
20.
Brinkman BM,
Zuijdeest D,
Kaijzel EL,
Breedveld FC,
Verweij CL.
Relevance of the tumor necrosis factor alpha (TNF alpha)
308 promoter
polymorphism in TNF alpha gene regulation.
J Inflamm
1995;
46:
32-41
[Medline].
21. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000; 1: 185-190 . [Medline]
22.
Huang SL,
Su CH,
Chang SC.
Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis.
Am J Respir Crit Care Med
1997;
156:
1436-1439
23.
Whyte M,
Hubbard R,
Meliconi R,
Whidborne M,
Eaton V,
Bingle C,
Timms J,
Duff G,
Facchini A,
Pacilli A, et al
.
. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.
Am J Respir Crit Care
Med
2000;
162:
755-758
24.
Schaaf BM,
Seitzer U,
Pravica V,
Aries SP,
Zabel P.
Tumor necrosis factor-
alpha
308 promoter gene polymorphism and increased tumor necrosis
factor serum bioactivity in farmer's lung patients.
Am J Respir Crit Care
Med
2001;
163:
379-382
25.
Camarena A,
Juarez A,
Mejia M,
Estrada A,
Carrillo G,
Falfan R,
Zuniga J,
Navarro C,
Granados J,
Selman M.
Major histocompatibility complex
and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease.
Am J Respir Crit Care Med
2001;
163:
1528-1533
26. Zhai R, Jetten M, Schins RP, Franssen H, Borm PJ. Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners. Am J Ind Med 1998; 34: 318-324 [Medline].
27.
Leger JP.
Occupational diseases in South African mines
a neglected
epidemic?
S Afr Med J
1992;
81:
197-201
[Medline].
28. Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, De Cock KM. HIV infection and silicosis: the impact of two potent risk factors on mycobacterial disease incidence in South African miners. AIDS 2000; 14: 2759-2768 [Medline].
29.
Corbett EL,
Murray J,
Churchyard GJ,
Herselman PC,
Clayton TC,
De
Cock KM,
Hayes RJ.
Use of mini-radiographs to detect silicosis: comparison of radiological with autopsy findings.
Am J Respir Crit Care
Med
1999;
160:
2012-2017
30. Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994; 150: 1460-1462 [Abstract].
31. Ng TP, Chan SL, Lee J. Predictors of mortality in silicosis. Respir Med 1992; 86: 115-119 [Medline].
32. International Labour Office. Guidelines for the use of ILO international classification of radiographs of pneumoconiosis. 1981;Series 22. ILO. Occupational Safety and Health, Geneva.
33. Chiappino G, Vigliani EC. Role of infective, immunological, and chronic irritative factors in the development of silicosis. Br J Ind Med 1982; 39: 253-258 [Medline].
34.
Koskinen H,
Tiilikainen A,
Nordman H.
Increased prevalence of HLA-Aw19 and of the phenogroup Aw19,B18 in advanced silicosis.
Chest
1983;
83:
848-852
35. Honda K, Kimura A, Dong RP, Tamai H, Nagato H, Nishimura Y, Sasazuki T. Immunogenetic analysis of silicosis in Japan. Am J Respir Cell Mol Biol 1993; 8: 106-111 .
36. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000; 12: 110-119 [Medline].
37.
Wilson AG,
Symons JA,
McDowell TL,
McDevitt HO,
Duff GW.
Effects of
a polymorphism in the human tumor necrosis factor alpha promoter on
transcriptional activation.
Proc Natl Acad Sci USA
1997;
94:
3195-3199
38.
Bayley JP,
de Rooij H,
van den Elsen PJ,
Huizinga TW,
Verweij CL.
Functional analysis of linker-scan mutants spanning the
376,
308,
244, and
238 polymorphic sites of the TNF-alpha promoter.
Cytokine
2001;
14:
316-323
[Medline].
This article has been cited by other articles:
![]() |
B. Yucesoy, V. J. Johnson, G. E. Kissling, K. Fluharty, M. L. Kashon, J. Slaven, D. Germolec, V. Vallyathan, and M. I. Luster Genetic susceptibility to progressive massive fibrosis in coal miners Eur. Respir. J., June 1, 2008; 31(6): 1177 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohtsuka, X-T. Wang, J. Saito, T. Ishida, and M. Munakata Genetic linkage analysis of pulmonary fibrotic response to silica in mice Eur. Respir. J., November 1, 2006; 28(5): 1013 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gambelli, P. Di, X. Niu, M. Friedman, T. Hammond, D. W. H. Riches, and L. A. Ortiz Phosphorylation of Tumor Necrosis Factor Receptor 1 (p55) Protects Macrophages from Silica-induced Apoptosis J. Biol. Chem., January 16, 2004; 279(3): 2020 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF] |
||||
![]() |
R Nadif, A Jedlicka, M Mintz, J-P Bertrand, S Kleeberger, and F Kauffmann Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction J. Med. Genet., February 1, 2003; 40(2): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |